Challenging Clinical Cases – A Walk Through Supplemental Therapy with Intravitreal Ranibizumab Therapy Following Treatment of Diabetic Macular Edema with the 0.19 mg Fluocinolone Acetonide Implant (ILUVIEN(®))

PURPOSE: There are limited published data regarding the use of supplemental intravitreal therapies in patients with diabetic macular edema (DME) following treatment with the 0.19 mg fluocinolone acetonide (FAc; ILUVIEN(®)) intravitreal implant. The aim of this report was to analyze five challenging...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int Med Case Rep J
Autors principals: Pessoa, Bernardete, Melo-Beirão, João, Meireles, Angelina, Menéres, Pedro
Format: Artigo
Idioma:Inglês
Publicat: Dove 2020
Matèries:
Case Series
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7501957/
https://ncbi.nlm.nih.gov/pubmed/32982484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IMCRJ.S262587
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars